期刊档案 · Agricultural and Biological Sciences-Food Science
Bioactive Carbohydrates and Dietary Fibre
ISSN 2212-6198 · Elsevier
Bioactive Carbohydrates and Dietary Fibre 中科院新锐版 医学 4区，影响因子 3.3（官网公布），混合开放获取，APC 约 3,340 美元，出版商公布投稿到接收约 155 天，2025 年发文 53 篇，ESCI、Scopus 收录。
研究范围
研究范围与定位
Bioactive Carbohydrates and Dietary Fibre 由 Elsevier 出版，属中科院医学大类。按 OpenAlex 近年发文统计，该刊主要发表 Food composition and properties、Polysaccharides and Plant Cell Walls、Microbial Metabolites in Food Biotechnology 等主题的论文，这 3 个主题约占 38%。（根据 OpenAlex 主题统计与中科院分区数据生成）
Bioactive Carbohydrates and Dietary Fibre is intended to be an international journal focused on dietary fibre, and bioactive carbohydrates (including bioactive polysaccharides, oligosaccharides and glycoproteins. It will include original studies and comprehensive reviews on the primary structure, molecular characteristics including conformation, size and shape, and bioactivities demonstrated by studies using in vitro, cell culture, animal and human clinical trials for understanding the action mechanisms and efficacy of bioactive carbohydrates from plants, fungi, animals and produced by biotechnology.Specific bioactivities such as reducing serum cholesterol, modulating blood glucose and insulin levels, fermentability in the gastrointestinal track, anti-tumor, anti-inflammatory, immune regulatory and anti-oxidant activities demonstrated by these bioactive carbohydrates are the main focus of this journal. It also covers the areas of interaction of dietary fibres, oligosaccharides, polysaccharides and glycoproteins with food matrices which may enhance or alter their efficacy, shelf-life stability of the bioactivities.Papers will cover such issues as: • Structural characterization of bioactive polysaccharides, oligosaccharides and glycoproteins • Conformation and molecular characteristics of bioactive polysaccharides, oligosaccharides and glycoproteins • Bioactivities of polysaccharides including: anti-cancer, immune modulation, anti-inflammatory, anti-oxidant etc • New anti-cancer polysaccharides from herbs • Recent advances in bioactive polysaccharides, oligosaccharides and glycoproteins • Analysis and physicochemical characterization of soluble and insoluble dietary fibre • Effects of dietary fibre on post-prandial blood glucose and/or insulin levels • Effect of dietary fibre on blood total and/or LDL cholesterol levels; • Effects of dietary fibre on gut function and ecology of microflora • Role of a diet rich in soluble fibre in reducing body weight • Development of dietary fibre industry • Animal and clinical trial studies • Updates on regulatory changes and legal constraints on nutritional dietary fibre and other food hydrocolloidsThe subject borders on medicine but is not a medical subject. The common factor for published papers is “bioactivity” and it's influence on health. Origin, husbanding, extraction, characterization, purification, cell culture, animal and clinical trials leading towards a medical or food supplemental applications will be considered. To be considered for this journal the research needs to cross-over from chemistry/biochemistry into biological investigation, with opportunities too for those who work on immune systems to contribute.Types of contribution: • Original research papers (full papers and short communications) • Invited reviews • Opinion pieces • Perspective commentaries.
摘自期刊官网 Aims & Scope
研究方向（LetPub）：Agricultural and Biological Sciences-Food Science
主编 Steve W. Cui出版商官网
编委会国家分布：中国大陆 13 位（约 37%）；主要国家 中国 13、加拿大 7、澳大利亚 4、中国香港 2、美国 2（共 35 位编委标注了国家） 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计，占比为近似值
- Food composition and propertiesNursing13%
- Polysaccharides and Plant Cell WallsAgricultural and Biological Sciences12.6%
- Microbial Metabolites in Food BiotechnologyNursing12.4%
- Polysaccharides Composition and ApplicationsAgricultural and Biological Sciences10.5%
- Probiotics and Fermented FoodsAgricultural and Biological Sciences5.2%
- Seaweed-derived Bioactive CompoundsAgricultural and Biological Sciences4.9%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance3.9%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology3.7%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表（ 2025年3月升级版）未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》（ 2026年3月发布）医学 4 区
| 类别 | 学科 | 分区 |
|---|---|---|
| 大类 | 医学 | 4 区 |
| 小类 | 食品科技FOOD SCIENCE & TECHNOLOGY | 3 区 |
Top 期刊：否综述期刊：未标注
期刊分区表（ 2023年12月旧的升级版）未收录
该期刊未被此版本分区表收录。
数据库收录
ESCIScopusLetPub
国际期刊预警名单：各版本均未列入LetPub
不同版本、大类与小类分别展示，不将不同评价口径合并为一个分区值；投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- 影响因子（出版商公布）
- 3.3出版商官网 ·
- CiteScore 2026-06
- 6.9LetPub ·
- CiteScore（出版商公布）
- 6.9出版商官网 ·
- SJR 2026-06
- 0.64LetPub ·
- SNIP 2026-06
- 0.73LetPub ·
- h-index
- 52OpenAlex ·
- i10-index
- 267OpenAlex ·
- 两年平均被引
- 3.85OpenAlex ·
- 自引率
- 3%LetPub ·
- Gold OA 文章占比
- 8.13%LetPub ·
发文规模
- 年文章数
- 47LetPub ·
逐年发文量 OpenAlex 统计 · 累计 571 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 40 | 4 | 12 |
| 2025 | 53 | 10 | 120 |
| 2024 | 65 | 11 | 477 |
| 2023 | 49 | 7 | 447 |
| 2022 | 37 | 2 | 366 |
| 2021 | 45 | 5 | 999 |
不同来源的统计口径与观测时间不同，页面保留各来源原值；“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
出版商公布的审稿周期 期刊官网自述数据
155 天投稿到接收
出版商统计口径以官网为准；本刊近 24 个月的文章日期尚未获得，因此以官方数据为准。
各来源数据
- 投稿到首次决定
- 14 天出版商官网 ·
- 外审后首次决定
- 70 天出版商官网 ·
- 投稿到接收
- 155 天出版商官网 ·
- 接收到发表
- 1 天出版商官网 ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本，置信度 0.5，不代表期刊承诺；“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
混合开放获取LetPub
订阅期刊，作者可付费选择开放获取发表。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 3,340 / EUR 3,120 / GBP 2,670 / JPY 414,260 | — | — | |
| 出版商官网 | USD 3,500 | — | — |
混合期刊的文章处理费仅在作者选择开放获取发表时收取；按订阅方式发表通常不收费。
费用以期刊官网为准；不同来源的观测时间可能不同，页面保留各来源原值，不做平均。
投稿要求
文章类型与投稿政策（官网）
投稿准备要点5 项，摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- 1–7 个
- 参考文献格式
- APA 格式
- Highlights（研究亮点）
- 必须提供
- 图文摘要
- 必须提供
接收的文章类型12 种
- book reviewOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- commentaryOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- letterOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- opinionOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- opinion piecesOpinion pieces will be invited only. It will cover opinions and/or comments on a paper, method or regulatory policies related to bioactive carbohydrates and die…未说明篇幅
- original researchOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- original research paperOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- original research papersOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- perspectiveOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- perspective commentariesPerspective Commentaries will include articles such as Letter to Editor to discuss some aspect of papers published in the journal; it will also include book rev…未说明篇幅
- reviewOriginal research papers should report the results of original research. The material should not have been previously published elsewhere, except in a prelimina…未说明篇幅
- review papersReview papers will be accepted in areas of topical interest and will normally focus on literature published over the previous five years.未说明篇幅
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、预印本
- AI 使用 Declaration of generative AI use
作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况。 模型中文摘要
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
原文 ↗出版商官网 ·- 作者资格 Group authorship
团体署名必须在投稿时于标题页声明，提交作者应在投稿系统的“Collaborative Author Groups”下注明该团体。 模型中文摘要
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
原文 ↗出版商官网 ·- 利益冲突 Declaration of competing interests
所有作者必须披露可能不当影响或偏颇其工作的财务和个人关系，并始终完成声明工具。 模型中文摘要
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
原文 ↗出版商官网 ·- 许可与版权 License options
作者将获得开放获取用户许可选项，建议在选择许可前审查这些选项及资助机构的许可要求。 模型中文摘要
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
原文 ↗出版商官网 ·- 开放获取 Open access
本刊提供开放获取选项，作者可参阅开放获取信息页面了解详情。 模型中文摘要
We refer you to our open access information page to learn about open access options for this journal.
原文 ↗出版商官网 ·- 同行评审 Peer review
本刊采用单盲同行评审，稿件通常至少由两名审稿人进行独立专家评估，录用与否由编辑决定。 模型中文摘要
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
原文 ↗出版商官网 ·- 预印本 Preprints
作者可依据Elsevier文章共享政策分享预印本，分享预印本不计为先前发表。 模型中文摘要
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
原文 ↗出版商官网 ·
摘录来自期刊官网页面，仅保留原文片段；“模型摘要”由 Workers AI 生成并经原文校验，以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Elsevier
- ISSN
- 2212-6198
- 官方链接
- 期刊主页 ↗LetPub
- 投稿系统 ↗出版商官网
- 专刊 / 特刊征稿 ↗出版商官网
常见问题
关于 Bioactive Carbohydrates and Dietary Fibre 的常见问题
Bioactive Carbohydrates and Dietary Fibre 是中科院几区期刊？
2026 年新锐版分区表中为医学 4区。不同版本与大小类分区不能混用。
Bioactive Carbohydrates and Dietary Fibre 的影响因子是多少？
期刊官网公布的影响因子为 3.3，属期刊自述数据，LetPub 暂无该刊的影响因子记录，CiteScore 为 6.9，h-index 为 52。
Bioactive Carbohydrates and Dietary Fibre 的审稿周期多长？
出版商公布的投稿到接收时间约为 155 天。文章统计只含被录用的稿件，出版商数据口径以官网为准，社区反馈来自投稿者样本，均不代表期刊承诺。
Bioactive Carbohydrates and Dietary Fibre 的投稿格式要求是什么？
据期刊作者指南：摘要：≤ 250 词；关键词：1–7 个；参考文献格式：APA 格式；Highlights：必须提供；图文摘要：必须提供。以上由模型从作者指南提取并逐项与原文核对，投稿前请以官网最新版本为准。
Bioactive Carbohydrates and Dietary Fibre 的编委会里有中国学者吗？
期刊官网编委会页面上标注了国家的 35 位编委中，中国大陆 13 位（约 37%）；人数最多的国家是 中国（13 位）、加拿大（7 位）、澳大利亚（4 位）。统计按编委会页面列出的机构国家计，仅供参考。
Bioactive Carbohydrates and Dietary Fibre 被哪些数据库收录？
据 LetPub 与 DOAJ 记录，Bioactive Carbohydrates and Dietary Fibre 被 ESCI、Scopus 收录。
Bioactive Carbohydrates and Dietary Fibre 是开放获取期刊吗？版面费多少？
Bioactive Carbohydrates and Dietary Fibre 为混合开放获取。选择开放获取发表时APC 约 3,340 美元。
来源与更新
本页事实来自 LetPub、出版商官网、OpenAlex；每个数字旁标注来源与观测日期，冲突数据保留各来源原值。LetPub 原始详情页：查看 ↗（2026-08-26 归档）。最近更新：。